Xcout Intel
CellX
CellX Biosolutions AG is an ETH Zurich-born startup founded in 2024 and headquartered in Zurich, Switzerland. The company specializes in developing microbial technologies to sustainably treat chemical waste and pollutants such as PFAS and microplastics.
Subscribe to see CellX’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CellX at a glance
CellX is a food and biotechnology company headquartered in Switzerland. It has raised at least $15.3M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $11M in May 2022. Xcout tracks 2 named people at CellX, including Dr. Estelle Clerc (CEO).
CellX leadership
- Dr. Estelle ClercCEO
- Geoffrey BesnierCOO
CellX funding rounds
At least $15.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $11M | 2 named | |
| Seed | $4.3M | 12 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
CellX competitors
A few of CellX's closest competitors — see the full list of competitors and alternatives →
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
StrainX Bioworks is a synthetic biology research company founded in 2023 that specializes in strain engineering, protein engineering, and precision fermentation to produce high-value alternatives.
Biota Inc. is a Boulder, Colorado-based company founded in 2024 that helps testing labs boost revenue and supports companies working in PFAS remediation.
ChemoSensoryX Biosciences SA is a biotechnology company that provides discovery products and services related to chemical communications mediated by human olfactory and taste receptors. Utilizing a proprietary technology platform and screening facilities, the company develops solutions for odor and taste management, including malodor blockers, pleasant odor enhancers, and applications for flavors, fragrances, and drug discovery.
Exobiosphere is a privately held space-biotech company headquartered in Esch-sur-Alzette, Luxembourg. Founded in 2024, its mission is to extend and improve life on Earth and in space by utilizing microgravity as a new dimension for biology to accelerate drug research.
Cemvita Factory is a Houston-based industrial biotechnology company that engineers microorganisms and biological processes to decarbonize heavy industries, including energy and mining. Its solutions target applications such as biomanufacturing, biomining, and the production of lower-carbon fuels and chemicals for industrial customers.
Get CellX's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CellX in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access